Anika Therapeutics | ANIK - EPS Earnings Per Share


Anika Therapeutics reported $0.13 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
Abbott USD 1.15 0.35 Mar/2026
Agenus USD -0.3 0.84 Dec/2025
Agios Pharmaceuticals USD -1.69 0.17 Mar/2026
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD -0.93 1.15 Mar/2026
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Halozyme Therapeutics USD 1.6 1.84 Mar/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Insmed USD -0.76 0.78 Mar/2026
Integra LifeSciences USD 0.54 0.29 Mar/2026
Intrexon USD -0.1 0.03 Jun/2024
J&J USD 2.7 0.24 Mar/2026
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
Ligand Pharmaceuticals USD 1.63 0.39 Mar/2026
MacroGenics USD -0.58 0.36 Mar/2026
Merit Medical Systems USD 0.86 0.18 Mar/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 1.88 0.35 Mar/2026
Smith & Nephew USD 0.59 0.27 Dec/2025
Stryker USD 2.6 1.87 Mar/2026
Veracyte USD 0.52 0.01 Mar/2026
Xencor USD -1.71 1.62 Mar/2026
Zimmer Biomet Holdings USD 2.09 0.33 Mar/2026